WEtech Alliance’s Post

Colorado Health & Tech Centers is excited to announce that it will host Summit Venture Studios, offered by Summit Impact Partners, a cutting-edge incubator designed to support the growth of innovative startups in the biotechnology and technology industries. Set in Greenwood Village/Denver, Colorado, the studios will offer a dynamic and collaborative environment where entrepreneurs can access mentorship, state-of-the-art resources, and flexible workspace to bring their groundbreaking ideas to life. Both Summit Impact Partners and Colorado Health & Tech Centers are dedicated to empowering the next generation of industry leaders by providing access to expert guidance, strategic partnerships, and a thriving ecosystem to drive business success and positive industry impact. Babak Kia, Ian Dickinson, Thomas Malcolm, Danny D. Martinez, Michael S. Rosen, Hamed Reyhanfard, Pharm.D, MBA, Colorado Office of Economic Development and International Trade, CO Hub for Health Impact, South Metro Denver Chamber, Colorado BioScience Association, Elevate Quantum, University of Colorado Boulder, CU Boulder Innovation & Entrepreneurship Initiative, CU Innovations, #Denverrealestate, #biotechnology, #Pharmaceutical, #biotech, #pharma, #innovation, #tech, #Technology, #CBSA, #CoBioscience, #cro , #cdmo , #laboratory,  #relocationspecialist, #Medicaldevice, #entrepreneurship, #SaudiArabia, #startups, #future, #India, #USA, #UK, #UAE, #biomanufacturing, #Quantum, #Quantumtechnology

It’s exciting to see Oregon policy makers eager to learn how the state can work to build and strengthen every level of the state’s biotech ecosystem. Our three big takeaways today were… 1) Venture creation often starts in academic labs after new intellectual property is filed. If the state worked to increase research funding to flagship institutions like Oregon State University, the University of Oregon, Portland State, and OHSU, we would likely see an increase in the number of patents filed in Oregon. Additionally, any funding used to reduce tuition costs or prevent further increasess would limit the burden of student-debt on Oregonians, making entrepreneurship less risky for young people who would otherwise be forced into a traditional career path. Either policy could increase the number of biotech (and general deeptech)companies in Oregon. 2) The Oregon Bioscience Incubator and OTRADI is a wonderful organization that provides an essential early-stage landing pad for startups in the form of low-cost laboratory space. However, there’s a lot of room for impactful growth for OBI as the steward of biotech in Oregon and the Pacific Northwest. We identified a list of aspirational peers for OBI like MassBio, The Engine, and other government and non-government organizations around the globe. These organizations provide a template for success and roadmap for growing the biotech industry in Oregon. In my opinion, the legislature should adopt policies to increase OBI funding for improved facilities, increased SBIR/STTR-matching, and enhanced programming for entrepreneurial education and investor relations. Implementing these changes will increase the chance of success for Oregon-grown startups. Moreover, when coupled with Portland’s low cost-of-living compared to hubs like SF & Boston, these changes could attract other startups to the region. 3) Finally, we discussed what incentives there are for successful companies grown in Oregon to stay in Oregon. We discussed the recent example of AbSci, a 100+ employee biotech company, which started in Portland but later moved to Vancouver, Washington for rational financial decisions — due in-part to Washington-state incentives. In my opinion, the state should work to assess and understand disparities between Oregon and other states’ (especially WA & CA) policies that incentivize companies to leave. Matching those incentives so Oregon companies stay in Oregon would be a great first step. More optimistically, the growth of biotech could be used to increase the number of companies in Portland’s urban core. Biotech companies, even those that leverage the latest laboratory automation tools, generally require their scientists be in-office 5 days/week to work in the lab. Policies from the state, or even the City of Portland, that support office-to-lab conversions would certainly be a boon for the industry and the City of Portland. Note, I’m biased here as someone working to grow an R&D team in Portland.

As we work to unveil the future of aging, we are thrilled to announce that we've been selected for the Yale Innovation Summit 2024 Virtual Showcase! Happening May 29th - 30th at the Yale University campus, we're excited to connect with leading investors, industry innovators, and fellow biotech pioneers at this premier event. Join us as we explore the future of longevity and share our mission to revolutionize the human experience. Interested in learning more about Eternity Biotech? Reach out to our team to schedule a meeting at the summit! In the meantime, let us know in the comments below what you're most looking forward to - see you there! #EternityBiotech #longevity #biotech #antiaging #YaleInnovationSummit #YaleInnovation24 #YaleVentures #innovation #entrepreneurship

For those biotech entrepreneurs out there - meeting today.

World record in biophysical screening Look at the screen: it measures 1536 samples faster than I can drink hot Espresso. For 16 years we had a dream: To measure a 1536 well plate in less than 10 minutes. To reduce the costs per data point to <0.2 USD. To enable biophysical uHTS. You want to screen 1,000,000 drug candidates? You want to get premium biophysical data? Yes, you can. Now. Humor is the key to everything: How fast or slow can you drink your Espresso? #biotechnology #entrepreneurship #startup ————————— I am Philipp - founder, CEO & business angel. My bootstrapped company NanoTemper is a global leader for biophysical tools for biotech. Like my content? Click my name + follow + 🔔

Checkout this special LifeSci Startup #podcast and learn more about #RESISouth and how Southeast Life Sciences connects the Southeast entrepreneurial ecosystem: https://lnkd.in/eDBZCj_f

As some one who has invented 4 classes of therapeutics and lead drug discovery for the companies that I founded or worked with over the last 30 years, I could never imagine measuring 1536 samples faster than I can drink my hot espresso. I am very sensitive to hot drinks so I drink it slower. Nanotemper's tech is amazing!!! Thanks Paren Patel and Tarek Al-Aydi for introducing me to this technology. This Nanotemper Technology for drug development is synonymous with what the NVIDIA technology is to AI !!! #innovation #drugdevelopment

From Rivals to Friends: A Journey Beyond Competition In the world of drug discovery, NanoTemper and Dynamic Biosensors stand out. We're known for our biophysical tools, essential in the quest for new medicines. At the marketplace, we're competitors.. I often run into Ralf Strasser, co-founder of Dynamic Biosensors. Competiton is hard. Two rivals, you might think, wouldn't mix. We compete for the same budget and the best people. Yet, through our passion for innovation, a shared belief in fair competition, we found common ground. It's not just about competing; it's about pushing each other to excel. This mutual respect transformed into friendship, proving that even competitors can unite on personal levels. In the end, we share a common vision that drives us: Our biophysical tools are build for science, to enable scientist to create a world where every disease is treatable. It feels very good to have friends, even in competition! How do you think about competition? #biotechnology #entrepreneurship #startup ————————— I am Philipp - founder, CEO & business angel. My bootstrapped company NanoTemper is a global leader for biophysical tools for biotech. Like my content? Click my name + follow + 🔔

Get GAP news: http://eepurl.com/sBQCT Resources for Research Institution POC, Startup Accelerator, and Venture GAP Fund Programs: https://lnkd.in/gRD4yDMC From concept to startup: How Mines helps turn innovative research into real-world companies  As Melissa Krebs was in the lab working on the biopolymer that would become Cleragel, it quickly became clear that the stretchable wound dressing, which improves healing in chronic wounds such as diabetic ulcers, was working so well that she could see a clear path throughFDA submission, approval and beyond. “We’re trying to solve a […] #innovation #university #research #gapfunding #proofofconcept #startup #accelerator #venture #commercialization

🌍 Global Entrepreneurship Week: North Carolina Biotechnology Center (NCBiotech) Spotlight We’re excited to highlight NCBiotech as a valued partner in the NSF-PTRM Engine ecosystem. For 40 years, NCBiotech has been committed to building North Carolina's global life sciences leadership with its first statewide office established 2 decades ago in the Piedmont Triad and Winston-Salem community.   NCBiotech has programs that help entrepreneurs and startups thrive and has invested in more than 279 North Carolina life sciences companies through its loan and convertible note programs. Companies receiving investment from NCBiotech's loan program have raised $8 billion, or $132 in follow-on funding for each $1 invested by NCBiotech. Its investment portfolio includes companies in therapeutics, medical devices, diagnostics, health IT, ag tech, and other areas of the life sciences.   Additionally, the organization hosts the NCBiotech Venture Challenge, a biennial competition awarding $300,000 to life sciences ventures, with awards presented at Triad BioNight. In 2024, BRINTER, a 3D bioprinting company and NSF-PTRM Engine partner was a regional finalist and won the Triad BioNight Entrepreneurial Excellence Award. In 2022, Plakous Therapeutics, another NSF-PTRM Engine partner, was the inaugural statewide winner of the Venture Challenge. To learn more about this valued partner, visit www.ncbiotech.org. #NSFengines #PTRME #NCbiotech #venturechallenge #triadbionight #globalentrepreneurshipweek #lifesciences